City Therapeutics
Drug DiscoveryWebsite
Operator of a biotechnology company intended to develop innovative, precise, and effective treatments for a wide range of diseases. The company focuses on creating medicines that use RNAi technology t...
Valuation
$285.5M
Market implied
Share Price
N/A
Total Raised
$139.5M
Last Round
Early Stage VC (Series A)
Oct 2024
Latest Funding Round
Early Stage VC (Series A)
Oct 8, 2024
$135M
raised
Investors
+8 other investors